Skip to main content

Table 2 Baseline variables

From: STeroids Against Radiculopathy (STAR) trial: a statistical analysis plan

 

Control group (n = xxx)

Intervention group 1 (n = xxx)

Intervention group 2 (n = xxx)

Participants characteristics

 Female

n/N (%)

n/N (%)

n/N (%)

 Age (years)

M ± SD

M ± SD

M ± SD

 BMI

M ± SD

M ± SD

M ± SD

 Vascular risk factors—no. (%)

x (%)

x (%)

x (%)

 Joint problems—no. (%)

x (%)

x (%)

x (%)

 Education level—no. (%)a

  Low

x (%)

x (%)

x (%)

  Moderate

x (%)

x (%)

x (%)

  High

x (%)

x (%)

x (%)

 Married or with a partner—no. (%)

x (%)

x (%)

x (%)

 Having a paid job—no. (%)

x (%)

x (%)

x (%)

Neurological examination

 Motor deficit— no. (%)

x (%)

x (%)

x (%)

 Sensory deficit—no. (%)

x (%)

x (%)

x (%)

 Pain on straight leg raising—no. (%)

x (%)

x (%)

x (%)

Level of herniation (MRI)- no (%)

 L3–4

x (%)

x (%)

x (%)

 L4–5

x (%)

x (%)

x (%)

 L5–S1

x (%)

x (%)

x (%)

Primary outcomes

 Leg pain intensity scoreb

M ± SD

M ± SD

M ± SD

 Back pain intensity scoreb

M ± SD

M ± SD

M ± SD

 Functional statusc

M ± SD

M ± SD

M ± SD

Secondary outcomes

 Quality of lifed

   
  1. BMI body mass index (calculated as weight in kilogrammes divided by height in metres squared)
  2. aLow indicates preschool, primary school or lower secondary school; moderate indicates higher secondary school or undergraduate; high indicates tertiary, university or postgraduate
  3. bMeasured by numeric rating scale (score range, 0–10); a higher score indicates more severe pain intensity
  4. cMeasured by Roland Disability Questionnaire (score range, 0–24); a higher score indicates worse functioning
  5. dMeasured by EQ-5D-5 L (score range, 0–1); a higher score indicates better quality of life